23Z-20496-10195
2 vaccinations
11 coded responses
20 check-ins
11 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 971 / OR
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Survey response — day 0, dose 1MedDRA: Paraesthesia — Feeling: GoodFree text: Tingling armsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-26
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain, Chills, Headache, Nausea, Pain, Pyrexia — Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaFree text: Never got check in during first few days, had fever 101.6, nausea, body aches, chills, chest pain, headache. I am a long hauler though so maybe accounts for more significant reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-29
-
2021-01-05
Survey response — day 14, dose 1MedDRA: Chest pain, Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest pain, nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Survey response — day 0, dose 2MedDRA: Dizziness, Feeling hot — Feeling: Fair · Site: Pain, ItchingFree text: Dizzy and hotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Chills, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-01-17
Survey response — day 7, dose 2MedDRA: Chest pain — Feeling: Fair · Headache, Fatigue or tirednessFree text: Chest pain-cardiacMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — day 14, dose 2MedDRA: Diarrhoea, Nausea — Feeling: FairFree text: Nausea, diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — day 21, dose 2MedDRA: Angina pectoris, Palpitations, Paraesthesia, Rhinorrhoea, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cardiac pain, tachycardia, palpitations, tingling extremities, runny nose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-07
- 2021-02-14
- 2021-02-21
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Night sweats — Feeling: FairFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
-
2021-05-27
Callback requested for1:00PM EST
-
2021-05-27
Call successfulCompleted over the phone
-
2021-07-11
Survey response — 6 months, dose 2MedDRA: Lung disorder, Obstructive airways disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Obstructive lung diseaseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-11
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-20
-
2022-01-10
Survey response — 12 months, dose 2MedDRA: Chest pain, Confusional state, Hallucination, Pelvic mass — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening chest pain, hallucinations, confusion, pelvic massMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-11
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech |
Call center
6 call center cases
3 successful · 3 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 3
1 wait over 3 months for a first call
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Tingling arms
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Never got check in during first few days, had fever 101.6, nausea, body aches, chills, chest pain, headache. I am a long hauler though so maybe accounts for more significant reaction
Release 1 — day 14, dose 1
Symptoms: Chest pain, nausea
Release 1 — day 0, dose 2
Systemic reaction (other): Dizzy and hot
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Chest pain
Release 2 — day 7, dose 2
Systemic reaction (other): Chest pain-cardiac
Release 2 — day 14, dose 2
Symptoms: Nausea, diarrhea
Release 3 — day 21, dose 2
Symptoms: Cardiac pain, tachycardia, palpitations, tingling extremities, runny nose.
Release 7 — 3 months, dose 2
Symptoms: Night sweats
Release 9 — 6 months, dose 2
Symptoms: Obstructive lung disease
Release 10 — 12 months, dose 2
Symptoms: Worsening chest pain, hallucinations, confusion, pelvic mass
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angina pectoris | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Confusional state | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Hallucination | · | · | ✓ |
| SD | Lung disorder | ○ | ✓ | ○ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SD | Obstructive airways disorder | ✓ | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pelvic mass | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release